DCA
COCH icon

DSG Capital Advisors’s Envoy Medical COCH Stock Holding History

DSG Capital Advisors’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$474K Hold
625,000
– – 0.07% 92
2026
Q1 		$416K Buy
+625,000
New +$426K 0.07% 102
2025
Q4 		– Sell
-163,642
Closed -$127K – 123
2025
Q3 		$127K Hold
163,642
– – 0.02% 122
2025
Q2 		$232K Hold
163,642
– – 0.04% 115
2025
Q1 		$213K Hold
163,642
– – 0.04% 118
2024
Q4 		$234K Buy
+163,642
New +$372K 0.04% 118

Other funds holding COCH

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACP
Arcus Capital Partners Atlanta, Georgia $242M AUM 20.33% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

DSG Capital Advisors's COCH Position: Q2 2026 in Review

DSG Capital Advisors held its Envoy Medical (COCH) position steady in Q2 2026 at 625,000 shares worth $474K. The position accounts for 0.07% of the portfolio, ranked #92.

DSG Capital Advisors first reported a position in COCH in Q4 2024 and has held it in 6 quarters since. 32 funds tracked by Wall St. Rank hold COCH as of Q2 2026.

  • DSG Capital Advisors held 625,000 shares of Envoy Medical worth $474K as of Q2 2026.
  • DSG Capital Advisors left its Envoy Medical share count unchanged in Q2 2026.
  • Envoy Medical made up 0.07% of DSG Capital Advisors's portfolio in Q2 2026, its #92 holding.
  • DSG Capital Advisors first reported a position in Envoy Medical in Q4 2024 and has held it in 6 quarters since.
  • 32 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2026.

Based on DSG Capital Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.